O
OrbiMed’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-45,200
| Closed | -$47.5M | – | 126 |
|
|
2024
Q3 | $47.5M | Buy |
45,200
+22,400
| +98% | +$23.5M | 0.86% | 34 |
|
|
2024
Q2 | $24M | Hold |
22,800
| – | – | 0.47% | 54 |
|
|
2024
Q1 | $21.9M | Buy |
22,800
+9,300
| +69% | +$8.95M | 0.4% | 60 |
|
|
2023
Q4 | $11.9M | Hold |
13,500
| – | – | 0.24% | 73 |
|
|
2023
Q3 | $11.1M | Hold |
13,500
| – | – | 0.24% | 80 |
|
|
2023
Q2 | $9.7M | Sell |
13,500
-10,500
| -44% | -$7.54M | 0.18% | 85 |
|
|
2023
Q1 | $19.7M | Buy |
+24,000
| New | +$19.7M | 0.39% | 67 |
|
|
2022
Q3 | – | Sell |
-22,200
| Closed | -$13.1K | – | 138 |
|
|
2022
Q2 | $13.1K | Buy |
+22,200
| New | +$13.1K | 0.24% | 77 |
|
|
2021
Q4 | – | Sell |
-13,560
| Closed | -$8.21M | – | 173 |
|
|
2021
Q3 | $8.21M | Buy |
+13,560
| New | +$8.21M | 0.09% | 138 |
|
|
2020
Q3 | – | Sell |
-30,900
| Closed | -$19.3M | – | 153 |
|
|
2020
Q2 | $19.3M | Buy |
30,900
+13,700
| +80% | +$8.54M | 0.27% | 79 |
|
|
2020
Q1 | $8.4M | Sell |
17,200
-192,100
| -92% | -$93.8M | 0.14% | 89 |
|
|
2019
Q4 | $78.6M | Sell |
209,300
-18,800
| -8% | -$7.06M | 1.12% | 32 |
|
|
2019
Q3 | $63.3M | Buy |
228,100
+12,300
| +6% | +$3.41M | 1.2% | 29 |
|
|
2019
Q2 | $67.5M | Buy |
215,800
+1,000
| +0.5% | +$313K | 1.05% | 32 |
|
|
2019
Q1 | $88.2M | Sell |
214,800
-7,300
| -3% | -$3M | 1.37% | 21 |
|
|
2018
Q4 | $83M | Sell |
222,100
-172,300
| -44% | -$64.4M | 1.53% | 17 |
|
|
2018
Q3 | $159M | Buy |
394,400
+21,900
| +6% | +$8.85M | 1.92% | 14 |
|
|
2018
Q2 | $129M | Sell |
372,500
-590,400
| -61% | -$204M | 1.53% | 16 |
|
|
2018
Q1 | $332M | Buy |
962,900
+108,300
| +13% | +$37.3M | 4.11% | 2 |
|
|
2017
Q4 | $321M | Buy |
854,600
+281,830
| +49% | +$106M | 4.06% | 3 |
|
|
2017
Q3 | $256M | Buy |
572,770
+106,000
| +23% | +$47.4M | 2.45% | 9 |
|
|
2017
Q2 | $229M | Buy |
466,770
+88,600
| +23% | +$43.5M | 2.4% | 9 |
|
|
2017
Q1 | $147M | Buy |
378,170
+22,870
| +6% | +$8.86M | 1.66% | 18 |
|
|
2016
Q4 | $130M | Hold |
355,300
| – | – | 1.66% | 20 |
|
|
2016
Q3 | $143M | Sell |
355,300
-154,600
| -30% | -$62.2M | 1.63% | 21 |
|
|
2016
Q2 | $178M | Sell |
509,900
-23,100
| -4% | -$8.07M | 1.86% | 16 |
|
|
2016
Q1 | $192M | Buy |
533,000
+50,000
| +10% | +$18M | 2.02% | 14 |
|
|
2015
Q4 | $262M | Sell |
483,000
-4,700
| -1% | -$2.55M | 2.37% | 13 |
|
|
2015
Q3 | $227M | Buy |
487,700
+25,900
| +6% | +$12M | 2.29% | 12 |
|
|
2015
Q2 | $236M | Buy |
461,800
+40,000
| +9% | +$20.4M | 1.97% | 20 |
|
|
2015
Q1 | $190M | Buy |
421,800
+31,600
| +8% | +$14.3M | 1.63% | 25 |
|
|
2014
Q4 | $160M | Buy |
390,200
+20,600
| +6% | +$8.45M | 1.53% | 27 |
|
|
2014
Q3 | $133M | Buy |
369,600
+43,000
| +13% | +$15.5M | 1.39% | 29 |
|
|
2014
Q2 | $92.3M | Sell |
326,600
-212,400
| -39% | -$60M | 1.08% | 34 |
|
|
2014
Q1 | $162M | Sell |
539,000
-199,800
| -27% | -$60M | 1.99% | 19 |
|
|
2013
Q4 | $203M | Buy |
738,800
+225,700
| +44% | +$62.1M | 2.99% | 8 |
|
|
2013
Q3 | $161M | Buy |
513,100
+162,000
| +46% | +$50.7M | 2.86% | 9 |
|
|
2013
Q2 | $79M | Buy |
+351,100
| New | +$79M | 1.67% | 22 |
|